Oxford University / AstraZeneca Publish positive vaccine data


Oxford University, along with AstraZeneca plc from Great Britain (AZN) – Get report It released promising data from an early-stage trial of a key coronavirus vaccine study in London on Monday that could lead to wider use by the end of the year.

The details, published in the British medical journal The Lancet, showed what the two groups described as humoral and cellular immune responses in human trials, with an acceptable safety profile. The study also showed “potent” cellular and humoral immunogenicity in all 1,077 participants in the Phase 1 / Phase II study.

.